Mefcare 40mg Injection

Introduction

Mefcare is a prescription medication that contains the active ingredient Drotaverine. It is available in the form of an injection and is commonly used for its muscle relaxant properties.

Uses

Mefcare is primarily prescribed to relieve smooth muscle spasms in various conditions, such as:

• Abdominal pain caused by gastrointestinal disorders
• Menstrual pain (dysmenorrhea)
• Biliary colic (gallbladder pain)
• Urinary tract disorders with associated pain

Dosage and Administration

The dosage and administration of Mefcare will be determined by your healthcare provider based on your specific condition and medical history. Follow their instructions carefully. Typically, the injection is administered intramuscularly (into the muscle) or intravenously (into the vein). The dosage may vary depending on the severity of the muscle spasm and individual response to the medication.

Mechanism of Action

Drotaverine, the active ingredient in Mefcare, works by inhibiting the enzyme phosphodiesterase-IV, which helps to relax and relieve smooth muscle spasms. This mechanism of action leads to the dilation of blood vessels and improved blood flow, reducing pain and discomfort associated with muscle spasms.

Side Effects

Common side effects may include:

• Nausea
• Vomiting
• Headache
• Dizziness
• Dry mouth

note that serious side effects are rare but can occur. If you experience any of the following serious side effects, seek medical attention immediately:

• Allergic reactions (such as rash, itching, swelling, severe dizziness, or difficulty breathing)
• Rapid or irregular heartbeat
• Severe abdominal pain or cramps
• Severe drowsiness or confusion

Drug Interactions

Mefcare may interact with other medications, including:

• Other muscle relaxants
• Medications that affect heart rate or rhythm
• Medications that affect blood pressure
• Sedatives or tranquilizers

inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements, to avoid potential interactions.

Precautions

Before using Mefcare, inform your healthcare provider about any known allergies, medical conditions, or medications you are taking. This medication may not be suitable for everyone, and precautions should be taken in the following cases:

• Hypersensitivity or allergic reactions to Drotaverine or any other component of the medication
• Severe liver or kidney disease
• Glaucoma (increased pressure in the eye)
• Pregnancy or breastfeeding

Additionally, Mefcare may interact with certain medications or substances, such as alcohol and grapefruit juice. It is advisable to avoid or limit the consumption of alcohol and grapefruit juice while using this medication.

Storage

Mefcare should be stored in a cool, dry place away from direct sunlight. It should be kept out of the reach of children. Do not use the medication if the packaging is damaged or if the expiry date has passed. Proper disposal methods should be followed as per local guidelines.

Patient Tips

• Follow the dosage instructions provided by your healthcare provider.
• Do not exceed the recommended dose or use the medication for longer than prescribed.
• If you miss a dose, contact your healthcare provider for further instructions.
• Inform your healthcare provider about any other medications you are taking before starting Mefcare.
• If you experience any unusual or persistent side effects, contact your healthcare provider.
• Store the medication properly as instructed to maintain its effectiveness and safety.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Drotaverine (International database) (Drugs.com) [Accessed 5 Jun. 2024] (online) Available at:
• Kanbur AS, Agarwal A, Rokade ML. Drotaverine-induced priapism. Indian J Urol. 2021 Jan-Mar;37(1):90-91. doi: 10.4103/iju.IJU_240_20. Epub 2021 Jan 1. [Accessed 22 Jun. 2024] Available at:
• No-Spa (International database) (Drugs.com) [Accessed 4 Jun. 2024] (online) Available at:
• Eder P, Kowalski P, Mastalerz-Migas A, Skrzydlo-Radomanska B, Cichy W, Proga K. Self-Medication with Drotaverine among Patients with Common Abdominal Symptoms and Treatment Efficacy from the Perspectives of Patients and General Practitioners-An Observational, Retrospective, Cross-Sectional Study Using Real-World Data. J Clin Med. 2022 Jun 1;11(11):3156. doi: 10.3390/jcm11113156. [Accessed 27 Jun. 2024] Available at: